Adamson Rh
- Co-authors
- Canellos GpHart LgThorgeirsson SsDeVita VtSeiji TakayamaTakashi SügimuraErnest BorekMellett Lb
- Topics
- Carcinogens and Genotoxicity Assessment (4 papers)RNA modifications and cancer (3 papers)Synthesis and Biological Evaluation (3 papers)
- Journals
- PubMedMunich Personal RePEc Archive (Ludwig Maximilian University of Munich)
- Partner nations
- United States
In The Last Decade
Adamson Rh
24 papers receiving 339 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 135
- Cancer Research 79
- Oncology 76
- Health, Toxicology and Mutagenesis 52
- Organic Chemistry 43
Countries citing papers authored by Adamson Rh
This map shows the geographic impact of Adamson Rh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adamson Rh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adamson Rh more than expected).
Fields of papers citing papers by Adamson Rh
This network shows the impact of papers produced by Adamson Rh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adamson Rh. The network helps show where Adamson Rh may publish in the future.
Co-authorship network of co-authors of Adamson Rh
This figure shows the co-authorship network connecting the top 25 collaborators of Adamson Rh. A scholar is included among the top collaborators of Adamson Rh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adamson Rh. Adamson Rh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Dietary heterocyclic amines as potential human carcinogens: experimental data from nonhuman primates. | 12 |
| 2 | Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines. | 8 |
| 3 | Metabolic processing and carcinogenicity of heterocyclic amines in nonhuman primates. | 38 |
| 4 | Carcinogenic potential of drugs. | 3 |
| 5 | DIVEMA-methotrexate: immune-adjuvant role of polymeric carriers linked to antitumor agents. | 10 |
| 6 | Disposition of chlorozotocin in rats and dogs. | 1 |
| 7 | Composition, associated tissue methyltransferase activity, and catabolic end products of transfer RNA from carcinogen-induced hepatoma and normal monkey livers. | 29 |
| 8 | Pharmacologic disposition of DL-alanosine in mice, rats, dogs, and monkeys. | 2 |
| 9 | Pharmacology of antitumor agents from higher plants. | 35 |
| 10 | Studies on the antitumor activity of gallium nitrate (NSC-15200) and other group IIIa metal salts. | 45 |
| 11 | Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma. | 16 |
| 12 | Evaluation of anti-tumor agents on tRNA methylase activity of leukemia L1210. | 2 |
| 13 | Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle. | 8 |
| 14 | Metabolism of cyclophosphamide-C14 by various marine species. | 14 |
| 15 | Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice. | 18 |
| 16 | Anesthesia in the rat. | 14 |
| 17 | Drug metabolism in marine vertebrates. | 63 |
| 18 | Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878). | 16 |
| 19 | Some pharmacologic properties of vincristine. | 14 |
| 20 | The neuromuscular blocking action of paromomycin. | 1 |
About Adamson Rh
Adamson Rh is a scholar working on Cancer Research, Toxicology and Organic Chemistry, having authored 25 papers that have together received 379 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (4 papers), RNA modifications and cancer (3 papers) and Synthesis and Biological Evaluation (3 papers). The work is most often cited by research in Cancer Research (79 citations), Pharmacology (36 citations) and Health, Toxicology and Mutagenesis (52 citations). Adamson Rh has collaborated with scholars based in United States. Frequent co-authors include Canellos Gp, Hart Lg, Thorgeirsson Ss, DeVita Vt, Seiji Takayama, Takashi Sügimura, Ernest Borek, Mellett Lb, C. L. Vogel and Daniel E. Gómez. Their work appears in journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.